1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea
CAS: 1333390-56-9
Ref. 3D-IDC39056
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
Regorafenib is a multikinase inhibitor that inhibits the activity of kinases in the RAS-RAF-MEK-ERK pathway, which are enzymes that regulate cell proliferation. It is an oral drug used to treat patients with metastatic colorectal cancer who have been previously treated with chemotherapy. The target of regorafenib is the oncogenic kinases in the RAS-RAF-MEK-ERK pathway, which are important for tumor growth and progression. Regorafenib has shown efficacy against many different types of cancers, including colorectal, thyroid, lung and renal cancers.
Chemical properties
Technical inquiry about: 3D-IDC39056 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
